ATE361092T1 - Verwendung des follikel stimulierenden hormons zur reduzierung von chromosomalen aberrationen der spermatozoen in mann - Google Patents
Verwendung des follikel stimulierenden hormons zur reduzierung von chromosomalen aberrationen der spermatozoen in mannInfo
- Publication number
- ATE361092T1 ATE361092T1 AT04766306T AT04766306T ATE361092T1 AT E361092 T1 ATE361092 T1 AT E361092T1 AT 04766306 T AT04766306 T AT 04766306T AT 04766306 T AT04766306 T AT 04766306T AT E361092 T1 ATE361092 T1 AT E361092T1
- Authority
- AT
- Austria
- Prior art keywords
- male
- follicle
- sperm
- stimulating hormone
- chromosomal aberrations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Farming Of Fish And Shellfish (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03102303 | 2003-07-25 | ||
| EP04100760 | 2004-02-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE361092T1 true ATE361092T1 (de) | 2007-05-15 |
Family
ID=34117532
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04766306T ATE361092T1 (de) | 2003-07-25 | 2004-07-23 | Verwendung des follikel stimulierenden hormons zur reduzierung von chromosomalen aberrationen der spermatozoen in mann |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20070037742A1 (de) |
| EP (1) | EP1673105B1 (de) |
| JP (1) | JP4718459B2 (de) |
| AT (1) | ATE361092T1 (de) |
| CY (1) | CY1107697T1 (de) |
| DE (1) | DE602004006286T2 (de) |
| DK (1) | DK1673105T3 (de) |
| ES (1) | ES2284052T3 (de) |
| HR (1) | HRP20070271T3 (de) |
| PL (1) | PL1673105T3 (de) |
| PT (1) | PT1673105E (de) |
| SI (1) | SI1673105T1 (de) |
| WO (1) | WO2005011726A1 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GR1008033B (el) * | 2012-03-29 | 2013-11-18 | Βασιλειος Τσιλιβακος | Μεθοδος διερευνησης της παρουσιας ενδοκυτταριων μολυσματικων παραγοντων σε κυτταρα του σπερματος |
| US20160024181A1 (en) | 2013-03-13 | 2016-01-28 | Moderna Therapeutics, Inc. | Long-lived polynucleotide molecules |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5017557A (en) * | 1987-07-24 | 1991-05-21 | Industria Farmaceutica Serono S.P.A. | Treatment of infertility with somatotrophin releasing factor |
| ATE148171T1 (de) * | 1989-02-21 | 1997-02-15 | Univ Washington | Modifizierte formen von fortpflanzungshormonen |
| US5508261A (en) * | 1991-06-18 | 1996-04-16 | University Of Medicine & Dentistry Of New Jersey | Analogs of glycoprotein hormones having altered receptor binding specificity and activity and methods for preparing and using same |
| US5883073A (en) * | 1997-04-03 | 1999-03-16 | Washington University | Single-chain double-alpha peptide |
-
2004
- 2004-07-23 ES ES04766306T patent/ES2284052T3/es active Active
- 2004-07-23 EP EP04766306A patent/EP1673105B1/de active Active
- 2004-07-23 SI SI200430323T patent/SI1673105T1/sl unknown
- 2004-07-23 JP JP2006521576A patent/JP4718459B2/ja not_active Expired - Fee Related
- 2004-07-23 WO PCT/EP2004/051593 patent/WO2005011726A1/en active IP Right Grant
- 2004-07-23 PT PT04766306T patent/PT1673105E/pt unknown
- 2004-07-23 US US10/565,763 patent/US20070037742A1/en not_active Abandoned
- 2004-07-23 AT AT04766306T patent/ATE361092T1/de active
- 2004-07-23 DE DE602004006286T patent/DE602004006286T2/de active Active
- 2004-07-23 DK DK04766306T patent/DK1673105T3/da active
- 2004-07-23 PL PL04766306T patent/PL1673105T3/pl unknown
-
2007
- 2007-06-11 HR HR20070271T patent/HRP20070271T3/xx unknown
- 2007-07-13 CY CY20071100936T patent/CY1107697T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1107697T1 (el) | 2013-04-18 |
| DK1673105T3 (da) | 2007-07-02 |
| PL1673105T3 (pl) | 2007-08-31 |
| JP2006528651A (ja) | 2006-12-21 |
| DE602004006286T2 (de) | 2008-01-03 |
| EP1673105A1 (de) | 2006-06-28 |
| EP1673105B1 (de) | 2007-05-02 |
| PT1673105E (pt) | 2007-06-20 |
| HRP20070271T3 (en) | 2007-07-31 |
| ES2284052T3 (es) | 2007-11-01 |
| JP4718459B2 (ja) | 2011-07-06 |
| DE602004006286D1 (de) | 2007-06-14 |
| WO2005011726A1 (en) | 2005-02-10 |
| SI1673105T1 (sl) | 2007-10-31 |
| US20070037742A1 (en) | 2007-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0415505A (pt) | agente terapêutico para mesotelioma | |
| CY1122522T1 (el) | Μετα αρσενικωδες νατριο για χρηση στην αγωγη του πολλαπλου μυελωματος | |
| ATE526991T1 (de) | Zusammensetzungen und ihre verwendungen für die gentherapeutische behandlung von knochenerkrankungen | |
| RS51106B (sr) | Derivati prolina i njihova upotreba kao inhibitora dipeptidil peptidaze iv | |
| CY1116768T1 (el) | Συνθεσεις οι οποιες περιεχουν βλαστοκυτταρα θηλυκης γαμετικης σειρας και μεθοδοι χρησης αυτων | |
| MX2012004258A (es) | Inhibidores de la tirosina quinasa de bruton. | |
| ATE430747T1 (de) | 2-pyrimidinyl-pyrazolopyridin-erbb- kinaseinhibitoren | |
| ECSP077421A (es) | Compuestos y composiciones como inhibidores de la actividad del receptor canabinoide 1 | |
| PL356846A1 (en) | Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase | |
| ATE319465T1 (de) | Therapeutische verwendung von extrakten aus sophora flavescens oder sophora subprostrata | |
| TW200621804A (en) | Ctla-4 antibody and aromatase inhibitor combination treatment for breast cancer | |
| TNSN08140A1 (de) | ||
| MXPA06014470A (es) | Formulaciones oftalmicas que incluyen antagonistas de alfa 1 selectivas. | |
| DE69935133D1 (de) | Antagoniste zur behandlung von cd11/cd18 adhäsionsrezeptor-vermittelten krankheiten | |
| TW200600087A (en) | Methods and compositions for treating amyloid-related diseases | |
| ATE450530T1 (de) | Zusammensetzungen zur verwendung als protein- kinase-inhibitoren | |
| MXPA05014166A (es) | Metodos y composiciones para tratar enfermedades relacionadas con amiloide. | |
| MX2009007337A (es) | Indazoles sustituidos con 5-piridinona. | |
| BRPI0509754A (pt) | inibidores de proteìna quinase c para o tratamento de doenças auto-imunes e de rejeição a transplante | |
| HK1068797A1 (en) | Use of long pentraxin ptx3 in the manufacture of amedicament for increasing reproductive ability in a female | |
| CY1106289T1 (el) | Χρηση αναστολεων υποδοχεος προγεστepονης για τη θepαπευτικη αντιμετωπιση του καρκινου του μαστου που ειναι ανθεκτικος σε στepοειδη | |
| MXPA05000765A (es) | Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos. | |
| TW200500079A (en) | Compositions and methods for treating coronavirus infection and sars | |
| WO2007041416A3 (en) | System and method for reviewing and implementing requested updates to a primary database | |
| ATE361092T1 (de) | Verwendung des follikel stimulierenden hormons zur reduzierung von chromosomalen aberrationen der spermatozoen in mann |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1673105 Country of ref document: EP |
|
| EEIH | Change in the person of patent owner |